• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

能否用 mTOR 抑制剂治疗 COVID-19?

Can We Use mTOR Inhibitors for COVID-19 Therapy?

机构信息

1Institute of Biodiversity and Ecosystem Research, Bulgarian Academy of Science, Sofia 1113, Bulgaria.

Pharmacognosy Research Laboratories and Herbal Analysis Services, School of Science, University of Greenwich, Central Avenue, Chatham-Maritime, Kent ME4 4TB, United Kingdom.

出版信息

Comb Chem High Throughput Screen. 2022;25(11):1805-1808. doi: 10.2174/1386207325666211130140923.

DOI:10.2174/1386207325666211130140923
PMID:34847842
Abstract

Infection by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) provokes acute inflammation due to extensive replication of the virus in the epithelial cells of the upper and lower respiratory system. The mammalian target of rapamycin (mTOR) is a l signalling protein with critical functions in cell growth, metabolism, and proliferation. It is known for its regulatory functions in protein synthesis and angiogenesis cascades. The structure of mTOR consists of two distinct complexes (mTORC1 and mTORC2) with diverse functions at different levels of the signalling pathway. By activating mRNA translation, the mTORC1 plays a key role in regulating protein synthesis and cellular growth. On the other hand, the functions of mTORC2 are mainly associated with cell proliferation and survival. By using an appropriate inhibitor at the right time, mTOR modulation could provide immunosuppressive opportunities as antirejection regimens in organ transplantation as well as in the treatment of autoimmune diseases and solid tumours. The mTOR also has an important role in the inflammatory process. Inhibitors of mTOR might indeed be promising agents in the treatment of viral infections. They have further been successfully used in patients with severe influenza A/H1N1 pneumonia and acute respiratory failure. The officially accepted mTOR inhibitors that have undergone clinical testing are sirolimus, everolimus, temsirolimus, and tacrolimus. Thus, further studies on mTOR inhibitors for SARS-CoV-2 infection or COVID-19 therapy are well merited.

摘要

严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染会引发急性炎症,因为病毒在上呼吸道和下呼吸道的上皮细胞中广泛复制。哺乳动物雷帕霉素靶蛋白(mTOR)是一种信号蛋白,在细胞生长、代谢和增殖中具有关键功能。它以其在蛋白质合成和血管生成级联中的调节功能而闻名。mTOR 的结构由两个不同的复合物(mTORC1 和 mTORC2)组成,在信号通路的不同水平具有不同的功能。mTORC1 通过激活 mRNA 翻译,在调节蛋白质合成和细胞生长方面发挥关键作用。另一方面,mTORC2 的功能主要与细胞增殖和存活有关。通过在适当的时间使用适当的抑制剂,mTOR 调节可能为器官移植中的抗排斥方案以及自身免疫性疾病和实体瘤的治疗提供免疫抑制机会。mTOR 在炎症过程中也具有重要作用。mTOR 抑制剂实际上可能是治疗病毒感染的有前途的药物。它们已成功用于治疗严重甲型流感 A/H1N1 肺炎和急性呼吸衰竭的患者。经过临床测试的官方认可的 mTOR 抑制剂有西罗莫司、依维莫司、替西罗莫司和他克莫司。因此,进一步研究 mTOR 抑制剂治疗 SARS-CoV-2 感染或 COVID-19 是非常值得的。

相似文献

1
Can We Use mTOR Inhibitors for COVID-19 Therapy?能否用 mTOR 抑制剂治疗 COVID-19?
Comb Chem High Throughput Screen. 2022;25(11):1805-1808. doi: 10.2174/1386207325666211130140923.
2
Pharmacological inhibition of mTORC1 but not mTORC2 protects against human disc cellular apoptosis, senescence, and extracellular matrix catabolism through Akt and autophagy induction.雷帕霉素靶蛋白复合物 1(mTORC1)的药理学抑制而非 mTORC2 的抑制通过 Akt 和自噬诱导来防止人椎间盘细胞凋亡、衰老和细胞外基质的分解代谢。
Osteoarthritis Cartilage. 2019 Jun;27(6):965-976. doi: 10.1016/j.joca.2019.01.009. Epub 2019 Feb 1.
3
Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: a tale of two complexes.多形性胶质母细胞瘤中mTORC1和mTORC2的不同信号传导机制:两种复合物的故事
Adv Biol Regul. 2015 Jan;57:64-74. doi: 10.1016/j.jbior.2014.09.004. Epub 2014 Sep 18.
4
A comparison of Ku0063794, a dual mTORC1 and mTORC2 inhibitor, and temsirolimus in preclinical renal cell carcinoma models.在肾细胞癌模型中比较双重 mTORC1 和 mTORC2 抑制剂 Ku0063794 与替西罗莫司。
PLoS One. 2013;8(1):e54918. doi: 10.1371/journal.pone.0054918. Epub 2013 Jan 22.
5
Everolimus inhibits anti-HLA I antibody-mediated endothelial cell signaling, migration and proliferation more potently than sirolimus.依维莫司比西罗莫司更能抑制抗 HLA I 抗体介导的内皮细胞信号转导、迁移和增殖。
Am J Transplant. 2014 Apr;14(4):806-19. doi: 10.1111/ajt.12669. Epub 2014 Mar 1.
6
Dengue activates mTORC2 signaling to counteract apoptosis and maximize viral replication.登革热激活 mTORC2 信号以抵抗细胞凋亡并最大限度地提高病毒复制。
Front Cell Infect Microbiol. 2022 Sep 12;12:979996. doi: 10.3389/fcimb.2022.979996. eCollection 2022.
7
PI3K/Akt/mTOR pathway: a potential target for anti-SARS-CoV-2 therapy.PI3K/Akt/mTOR 通路:抗 SARS-CoV-2 治疗的潜在靶点。
Immunol Res. 2022 Jun;70(3):269-275. doi: 10.1007/s12026-022-09268-x. Epub 2022 Feb 2.
8
Differential effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway in acute lymphoblastic leukemia.针对 PI3K/AKT/mTOR 通路的选择性抑制剂在急性淋巴细胞白血病中的差异效应。
PLoS One. 2013 Nov 14;8(11):e80070. doi: 10.1371/journal.pone.0080070. eCollection 2013.
9
Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2.mTOR的活性位点抑制剂靶向mTORC1和mTORC2的雷帕霉素抗性输出。
PLoS Biol. 2009 Feb 10;7(2):e38. doi: 10.1371/journal.pbio.1000038.
10
Structural Aspects of mTOR Inhibitors: Search for Potential Compounds.mTOR 抑制剂的结构方面:寻找潜在的化合物。
Anticancer Agents Med Chem. 2022;22(6):1037-1055. doi: 10.2174/1871520621666210720121403.

引用本文的文献

1
p70S6K as a Potential Anti-COVID-19 Target: Insights from Wet Bench and In Silico Studies.p70S6K 作为一种有潜力的抗 COVID-19 靶点:来自湿实验和计算机模拟研究的见解。
Cells. 2024 Oct 24;13(21):1760. doi: 10.3390/cells13211760.
2
Repurposing clinically available drugs and therapies for pathogenic targets to combat SARS-CoV-2.重新利用临床可用药物和疗法针对致病靶点来对抗新型冠状病毒。
MedComm (2020). 2023 May 14;4(3):e254. doi: 10.1002/mco2.254. eCollection 2023 Jun.
3
Gene Networks of Hyperglycemia, Diabetic Complications, and Human Proteins Targeted by SARS-CoV-2: What Is the Molecular Basis for Comorbidity?
高血糖、糖尿病并发症与 SARS-CoV-2 作用的人类蛋白的基因网络:共病的分子基础是什么?
Int J Mol Sci. 2022 Jun 29;23(13):7247. doi: 10.3390/ijms23137247.
4
Challenges of rapamycin repurposing as a potential therapeutic candidate for COVID-19: implications for skeletal muscle metabolic health in older persons.雷帕霉素再利用作为 COVID-19 潜在治疗候选药物的挑战:对老年人骨骼肌代谢健康的影响。
Am J Physiol Endocrinol Metab. 2022 Jun 1;322(6):E551-E555. doi: 10.1152/ajpendo.00064.2022. Epub 2022 May 6.
5
Translational Control of COVID-19 and Its Therapeutic Implication.新冠病毒的翻译调控及其治疗意义。
Front Immunol. 2022 Mar 29;13:857490. doi: 10.3389/fimmu.2022.857490. eCollection 2022.